Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by MyKnighton Mar 11, 2020 11:50am
74 Views
Post# 30793478

RE:RE:Do not vote no, espesially when the two trolls

RE:RE:Do not vote no, espesially when the two trollsIf I follow your logic and we have a 30 Millions $ Dillution...
Nobody here would be buying... our new CEO and friend would buy.
  • they would buy at the market price.
  • Price would stay at the ame price can't go any lower or increase because of the size
And then what the new CEO who own Millions of share does a reverse split
  • Price goes up 100 and Number of stock Div by 100
And then what..... The CEO would be in the same boat then us, he would have all of the interest to see is copany go up? 



RE:Do not vote no, espesially when the two trolls

A vote yes will result in you losing up to 80% more on top of what you've probably already lost. You can't expect a 100 to 1 reverse split and 40+ million dollars of dilution (plus what theyll have to dilute again later on for more funding) and to make returns. It really is straight forward. It will only benefit kaly, stero and talent insiders and ruin shareholders. There has been enough dilution and it is time for a partner or licensee to do some funding.
[/quote]
Bullboard Posts